Zydus recalls single lot of blood thinner warfarin

Zydus Pharmaceuticals is recalling a single lot of the drug warfarin after receiving a complaint that some of the tablets are too large.

Zydus says it is recalling all of warfarin lot MM5767 with an expiration date of June 2014. The company says it has not received any reports of patient injury or harm.

Warfarin is a blood thinner widely used to prevent blood clots in patients with irregular heartbeats, or a history of heart attack. An overdose of could cause excessive bleeding and potentially be fatal.

The drugmaker says the affected products were distributed to wholesalers, retailers and mail order providers nationwide between November and December 2012.

Anyone with the product should stop selling or using it immediately and call 1-800-967-5952 to arrange its return to the manufacturer.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

New blood thinner beats older drug for vein clots

Feb 20, 2013

(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...

Kcentra approved to stop severe bleeding in heart patients

Apr 30, 2013

(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...

Recommended for you

Health care M&A leads global deal surge

Nov 23, 2014

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and ...

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.